Managing side effects during titration The titration process is designed to help make side effects more manageable
Current diabetes guidelines recommend multifactorial CV risk management and the preferential use of a glucagon-like peptide-1 receptor agonist (GLP-1RA) or sodiumglucose cotransporter-2 inhibitor with proven CV benefits as a first choice add-on to metformin in patients with T2D and established atherosclerotic CVD [2, 4]
Please call our phone number listed on the website at least 24 hours before your scheduled appointment to reschedule or cancel
You can keep track of doses with a calendar or phone app
Liraglutide, semaglutide and dulaglutide have demonstrated cardiovascular benefits, and Wegovy recently added to this evidence base: in the SELECT trial, patients on Wegovy had a 20% lower incidence of heart attack, stroke or death from heart disease compared to those on a placebo
By the end, you will never second-guess the color of your tirzepatide again
